Regulation of maspin in placental development
maspin 在胎盘发育中的调节
基本信息
- 批准号:6637777
- 负责人:
- 金额:$ 9.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:cell migration cell morphology cell motility clinical research endometrium enzyme activity enzyme mechanism gene expression genetic regulation growth /development human genetic material tag human tissue hypoxia patient oriented research placenta preeclampsia prenatal growth disorder protease inhibitor serine proteinases superoxide dismutase tissue /cell culture transfection trophoblast tumor suppressor genes western blottings
项目摘要
DESCRIPTION (provided by applicant): Placental invasion is a highly regulated process and impairment results in pathologic obstetric conditions such as preeclampsia and intra-uterine growth restriction (IUGR). Further identification of factors that play a role in modifying this invasive ability of cytotrophoblasts will contribute to a better understanding of this unique developmental process. We have demonstrated a specific timeline for the expression of maspin, novel tumor suppressor gene in placental invasion and development. Our findings show that maspin is maximally expressed in the third trimester with low levels of expression in the first trimester of pregnancy. The specific aims of this proposal are 1) To measure the biological consequence(s) of maspin up regulation in human cytotrophoblasts with respect to invasion, motility and morphogenesis in vitro 2) Examine the role of hypoxia in regulating maspin expression in cytotrophoblasts 3) Compare the abundance of maspin/manganese superoxide dismutase mRNA and protein in placentas from women with term and preterm deliveries, with and without preeclampsia. The research design will include using adenoviral approach to transfect maspin into primary trophoblast cultures during the first and second testers and examine the effects of this transfection on cell invasion, migration, motility and morphogenesis. Next, the effects of hypoxia on maspin expression and the role of hypoxia-inducible factor in mediating these effects will be examined. Finally, will confirm our hypothesis using an in vivo model of hypoxia and impaired cytotrophoblast invasion namely preeclampsia. Maspin expression will be compared in placentae from women with preeclampsia to those from normal controls using real-time PCR. The long-term objectives of this project are two-fold, first, to understand the significance and mechanism(s) of action of tumor suppressor genes such as maspin in human placental development second, to identify pathological processes during gestation arising from alterations of maspin expression. Information revealed in this study could have profound implications on therapeutic strategies for clinical conditions associated with decreased cytotrophoblast invasion such as preeclampsia and IUGR. In addition, any important new information that may be obtained about the putative role of maspin during embryonic development may help elucidate the biological significance of its loss during tumor progression.
描述(由申请人提供):胎盘入侵是一个高度调节的过程,损害导致病理性产科状况,例如先兆子痫和 - 局内生长限制(IUGR)。进一步识别在修改细胞增生细胞的这种侵入性能力方面发挥作用的因素将有助于更好地理解这一独特的发展过程。我们已经证明了Maspin表达的特定时间表,Maspin,新型肿瘤抑制基因在胎盘侵袭和发育中。我们的发现表明,在妊娠前三个月表达低水平的三个月中,马斯皮素是最大表达的。该提案的具体目的是1)测量Maspin的生物学后果(S)在人类细胞增多质细胞中的调节在体外的侵袭,运动性和形态发生方面的生物学作用2)检查缺氧在调节MASPOPHRASTS中的MASPIN表达中的缺氧在调节MASPIROPHASTS中的培养基中的培养基/蛋白酶超级氧化物中的培养基中的培养基超级氧化物中的术语序列序列序言,该作用与Mangutsexexiidide的培养基中的培养量相似。早产,有和没有先兆子痫。研究设计将包括使用腺病毒方法在第一和第二个测试仪期间将Maspin转染到原代滋养细胞培养物中,并检查这种转染对细胞侵袭,迁移,运动和形态发生的影响。接下来,将研究缺氧对Maspin表达的影响以及缺氧诱导因子在介导这些作用中的作用。最后,将使用缺氧的体内模型证实我们的假设,并损害了细胞增生细胞侵袭,即先兆子痫。使用实时PCR,将在胎盘中比较Maspin表达与正常对照的胎盘表达。该项目的长期目标首先是两倍,以了解肿瘤抑制基因(例如MASPIN)在人胎盘发育中的重要性和机制,以鉴定由Maspin表达改变引起的妊娠过程中的病理过程。这项研究中揭示的信息可能对与胞质质细胞侵袭(如先兆子痫和IUGR)相关的临床状况的治疗策略具有深远的影响。此外,关于Maspin在胚胎发育过程中推定的作用的任何重要新信息都可能有助于阐明其在肿瘤进展过程中损失的生物学意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANUJA DOKRAS其他文献
ANUJA DOKRAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANUJA DOKRAS', 18)}}的其他基金
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 9.8万 - 项目类别:
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10616771 - 财政年份:2022
- 资助金额:
$ 9.8万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
9286789 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
9924273 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
10155513 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
- 批准号:
10237711 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
- 批准号:
10613338 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
- 批准号:
10378739 - 财政年份:2017
- 资助金额:
$ 9.8万 - 项目类别:
DIAGNOSTIC MARKERS FOR EARLY DETECTION AND TREATMENT OF PRETERM PREGNANCIES
早孕早期检测和治疗的诊断标志物
- 批准号:
7604876 - 财政年份:2007
- 资助金额:
$ 9.8万 - 项目类别:
CARDIOVASCULAR RISK FACTORS IN WOMEN WITH PCOS
多囊卵巢综合征女性的心血管危险因素
- 批准号:
7604877 - 财政年份:2007
- 资助金额:
$ 9.8万 - 项目类别:
相似国自然基金
细胞骨架蛋白MreB调控大肠杆菌细胞形态与通透性变化的机理研究
- 批准号:32371542
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
温度调控星形胶质细胞形态发育机制探究
- 批准号:32370877
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
类受体激酶MUSTACHES调节拟南芥保卫细胞形态建成的分子机制
- 批准号:32360088
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
星形胶质细胞形态重建对脑功能的影响
- 批准号:
- 批准年份:2022
- 资助金额:105 万元
- 项目类别:
MYB16/106调控花瓣锥形细胞形态建成的研究
- 批准号:32200280
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cell fate determination technique by single cell morphology design using gel-micromachining technique
使用凝胶微加工技术通过单细胞形态设计确定细胞命运的技术
- 批准号:
23K17723 - 财政年份:2023
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Optimizing triple negative breast cancer therapy based on immune cell morphology
基于免疫细胞形态优化三阴性乳腺癌治疗
- 批准号:
468140 - 财政年份:2022
- 资助金额:
$ 9.8万 - 项目类别:
Operating Grants
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
- 批准号:
RGPIN-2018-05756 - 财政年份:2022
- 资助金额:
$ 9.8万 - 项目类别:
Discovery Grants Program - Individual
Comprehensive and multi-resolution mapping of cell morphology and wiring through X-ray holographic nano-tomography
通过 X 射线全息纳米断层扫描对细胞形态和布线进行全面的多分辨率绘图
- 批准号:
10376584 - 财政年份:2021
- 资助金额:
$ 9.8万 - 项目类别:
ERM proteins and cell morphology in the retina
视网膜中的 ERM 蛋白和细胞形态
- 批准号:
RGPIN-2018-05756 - 财政年份:2021
- 资助金额:
$ 9.8万 - 项目类别:
Discovery Grants Program - Individual